S&P 500 7,708 -0.52% Nasdaq 26,331 -0.97% Dow Jones 53,463 -0.57% FTSE 100 10,726 -0.43% DAX 25,969 -1.26% Nikkei 225 66,217 -3.63% Hang Seng 25,698 +1.19% WTI Crude 86.45 +2.31% Gold 4,544 +2.87% US 10-Year Treasury Yield 4.653 +0.26% S&P 500 7,708 -0.52% Nasdaq 26,331 -0.97% Dow Jones 53,463 -0.57% FTSE 100 10,726 -0.43% DAX 25,969 -1.26% Nikkei 225 66,217 -3.63% Hang Seng 25,698 +1.19% WTI Crude 86.45 +2.31% Gold 4,544 +2.87% US 10-Year Treasury Yield 4.653 +0.26%

LATEST

BitGo secures South Korea virtual asset license, says it's the first global crypto company to do so●Bitcoin approaches $72,000 as Strategy and Coinbase continue rally●Phoenix Equity Partners backs Irish occupational health provider Medmark●Vijay Shekhar Sharma's Resilient Asset Management offloads 1.92 crore Paytm shares; details here●Meesho shares hit 3-month high as bull run extends to fourth day, up 85% from IPO price●Our 4-year-old son has $100,000 in his 529 account. Should we buy him stocks instead?●India’s family office wealth to grow 1.5x in three years as ultra-rich shift strategies: Report●Moderna’s Shift to Cancer Company Lifts Stock Up 177%●BitGo secures South Korea virtual asset license, says it's the first global crypto company to do so●Bitcoin approaches $72,000 as Strategy and Coinbase continue rally●Phoenix Equity Partners backs Irish occupational health provider Medmark●Vijay Shekhar Sharma's Resilient Asset Management offloads 1.92 crore Paytm shares; details here●Meesho shares hit 3-month high as bull run extends to fourth day, up 85% from IPO price●Our 4-year-old son has $100,000 in his 529 account. Should we buy him stocks instead?●India’s family office wealth to grow 1.5x in three years as ultra-rich shift strategies: Report●Moderna’s Shift to Cancer Company Lifts Stock Up 177%●

Asia

Moderna’s Cancer Vaccine Breakthrough: What It Means for the Stock

Markets-Economic Times · 3h ago · 🇮🇳 India

Moderna’s Cancer Vaccine Breakthrough: What It Means for the Stock

Moderna’s personalised mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, triggering a sharp stock rally and boosting hopes for mRNA-based cancer treatments beyond COVID-19.

Read the full story at Markets-Economic Times →

More Asia

Vijay Shekhar Sharma's Resilient Asset Management offloads 1.92 crore Paytm shares; details here

mint - markets · 34m ago

Meesho shares hit 3-month high as bull run extends to fourth day, up 85% from IPO price

mint - markets · 35m ago

India’s family office wealth to grow 1.5x in three years as ultra-rich shift strategies: Report

Markets-Economic Times · 50m ago

India's REIT sector has substantial room to grow: CareEdge Ratings

Markets-Economic Times · 55m ago